Author： Giuliani S. Guelfi M. Toulouse M. Bueno L. Lecci A. Tramontana M. Criscuoli M. Maggi C.A.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.415, Iss.1, 2001-03, pp. : 61-71
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
By Seabrook G.R. Shepheard S.L. Williamson D.J. Tyrer P. Rigby M. Cascieri M.A. Harrison T. Hargreaves R.J. Hill R.G.
European Journal of Pharmacology, Vol. 317, Iss. 1, 1996-12 ,pp. :
SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist
By Anthes J.C. Chapman R.W. Richard C. Eckel S. Corboz M. Hey J.A. Fernandez X. Greenfeder S. McLeod R. Sehring S. Rizzo C. Crawley Y. Shih N.-Y. Piwinski J. Reichard G. Ting P. Carruthers N. Cuss F.M. Billah M. Kreutner W. Egan R.W.
European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. :
By Robineau P. Lonchampt M. Kucharczyk N. Krause J.E. Regoli D. Fauchere J.-L. Prost J.-F. Canet E.
European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. :